Clinical Performance of the Mainz Biomed Colorectal Cancer Screening Test for Colorectal Cancer and Advanced Adenoma
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age45+
SponsorMainz Biomed
About this trial
This study is to determine how the Mainz Biomed Colorectal Cancer Screening Test works when used in people aged ≥45 years of age and at an average risk of developing colorectal cancer.
Eligibility criteria
Qualifiers
Subject is any sex and ≥45 years of age
Subject must be advised to have or be scheduled for a screening colonoscopy
no prior diagnosis of colorectal cancer, adenomatous polyps, or inflammatory bowel disease
Inflammatory bowel disease (IBD) including chronic ulcerative colitis (CUC) and Crohn's disease
Disqualifiers
Subject had any precancerous findings on most recent colonoscopy.
Subject has a history of abnormal imaging suggesting colorectal cancer (e.g., colonography, MRI, CT, barium enema)
Subject has a history of any of the following cancers: oral, head and neck, lung, esophagus, gastric, biliary/liver, pancreatic, small bowel, or appendiceal
Subject has had a positive non-invasive screening diagnostic within the associated recommended intervals
Trial design
Treatments tested in this trial
- Mainz Biomed Colorectal Cancer Screening Test
Treatment groups
15,000 Participants
are divided into 1 treatment groupLocations
Sponsors and collaborators
Source ClinicalTrials.gov